Atlas Trials

Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8

RecordFirmDate
Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers (NCT05296005)Ohio State University Comprehensive Cancer Center2025-12-31
Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma (NCT05041153)M.D. Anderson Cancer Center2022-02-14
Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer (NCT04929392)City of Hope Medical Center2022-01-25
Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery (NCT04391049)NRG Oncology2021-12-02
Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer (NCT04660760)Academic and Community Cancer Research United2021-06-16
Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers (NCT04460937)National Cancer Institute (NCI)2021-04-09
Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer (NCT04522336)M.D. Anderson Cancer Center2020-09-16
Use of Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy for the Treatment of Resectable Esophageal or Gastroesophageal Junction (GEJ) Adenocarcinoma (NCT04097028)Roswell Park Cancer Institute2019-12-20
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study (NCT03707574)National Cancer Institute (NCI)2019-07-16
Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal Adenocarcinoma (NCT03784326)M.D. Anderson Cancer Center2019-02-19

Track Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8 automatically

Every clearance here is in the API, with alerts when new ones post.